MTOR and hepatocellular carcinoma: To better understand the data obtained by the ex vivo study discussed above, we elucidated the effect of metformin on SIRT-3 and p-mTOR protein expression in three different HCC cell lines, also evaluating the impact of the drug alone and in association with sorafenib on proliferation and apoptosis induction.